Progress of prediction and early diagnosis of cancer therapy-related cardiovascular toxicity
Cancer is the second leading cause of mortality worldwide,and a quarter of global cancer-related deaths occur in China.At present,cardiovascular disease has emerged as the second most common cause of death among cancer survivors subsequent to cancer recurrence and metastasis.Accurate prediction and early diagnosis of potential cardiovascular toxicity during cancer treatment could not only optimize patients'clinical outcomes but also could alleviate the burden on the healthcare system.This article provides a comprehensive overview of recent research pertaining to predicting and early diagnosing cancer therapy-related cardiovascular toxicity,offering valuable insights into identifying high-risk patients.
国家科技期刊平台
NSTL
万方数据
维普
